IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 203 filers reported holding IMMUNOMEDICS INC in Q2 2018. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $31,604,036,000 | +138.2% | 371,681 | -0.7% | 0.02% | +112.5% |
Q2 2020 | $13,266,503,000 | +73.6% | 374,337 | -34.0% | 0.01% | +60.0% |
Q1 2020 | $7,642,310,000 | -44.2% | 566,937 | -12.5% | 0.01% | -37.5% |
Q4 2019 | $13,706,771,000 | -21.0% | 647,768 | -50.5% | 0.01% | -33.3% |
Q3 2019 | $17,348,125,000 | -2.8% | 1,308,305 | +1.6% | 0.01% | -7.7% |
Q2 2019 | $17,854,187,000 | -15.4% | 1,287,252 | +17.2% | 0.01% | -18.8% |
Q1 2019 | $21,092,793,000 | +103.3% | 1,098,011 | +51.0% | 0.02% | +77.8% |
Q4 2018 | $10,373,691,000 | -24.7% | 726,958 | +9.9% | 0.01% | -10.0% |
Q3 2018 | $13,773,650,000 | -15.0% | 661,241 | -3.4% | 0.01% | -16.7% |
Q2 2018 | $16,210,566,000 | +1319.7% | 684,857 | +776.3% | 0.01% | +1100.0% |
Q1 2018 | $1,141,858,000 | +8.5% | 78,156 | +20.0% | 0.00% | 0.0% |
Q4 2017 | $1,052,808,000 | +109.7% | 65,149 | +81.4% | 0.00% | – |
Q3 2017 | $502,035,000 | +61.4% | 35,911 | +1.9% | 0.00% | – |
Q2 2017 | $311,107,000 | -28.6% | 35,233 | -47.6% | 0.00% | – |
Q1 2017 | $435,437,000 | +806264.8% | 67,301 | +361.2% | 0.00% | – |
Q4 2016 | $54,000 | -53.4% | 14,592 | -59.1% | 0.00% | – |
Q3 2016 | $116,000 | +39.8% | 35,692 | 0.0% | 0.00% | – |
Q2 2016 | $83,000 | -27.8% | 35,692 | -22.2% | 0.00% | – |
Q1 2016 | $115,000 | -18.4% | 45,892 | 0.0% | 0.00% | – |
Q4 2015 | $141,000 | +78.5% | 45,892 | 0.0% | 0.00% | – |
Q3 2015 | $79,000 | -45.5% | 45,892 | +28.6% | 0.00% | – |
Q2 2015 | $145,000 | +13.3% | 35,692 | +6.9% | 0.00% | – |
Q1 2015 | $128,000 | -14.1% | 33,392 | +7.7% | 0.00% | – |
Q4 2014 | $149,000 | +29.6% | 30,992 | 0.0% | 0.00% | – |
Q3 2014 | $115,000 | +1.8% | 30,992 | 0.0% | 0.00% | – |
Q2 2014 | $113,000 | -13.1% | 30,992 | 0.0% | 0.00% | – |
Q1 2014 | $130,000 | +13.0% | 30,992 | +23.5% | 0.00% | – |
Q4 2013 | $115,000 | -25.8% | 25,092 | 0.0% | 0.00% | – |
Q3 2013 | $155,000 | +13.1% | 25,092 | 0.0% | 0.00% | – |
Q2 2013 | $137,000 | – | 25,092 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 1,711,067 | $2,943,000 | 1.70% |
J.P. Turner & Co Capital Mnagement, LLC | 248,625 | $428,000 | 0.44% |
Orbimed Advisors | 3,323,000 | $5,716,000 | 0.06% |
BALYASNY ASSET MANAGEMENT L.P. | 2,004,078 | $3,447,000 | 0.02% |
WOLVERINE ASSET MANAGEMENT LLC | 5,870 | $1,018,000 | 0.02% |
SIGNET FINANCIAL MANAGEMENT, LLC | 44,675 | $77,000 | 0.02% |
SVB WEALTH LLC | 195,000 | $335,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 288,900 | $497,000 | 0.01% |
J.P. Turner & Co Capital Mnagement, LLC | 153,900 | $8,000 | 0.01% |
BALYASNY ASSET MANAGEMENT L.P. | 640,400 | $1,101,000 | 0.01% |